Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Pandoraon Oct 02, 2021 3:08pm
207 Views
Post# 33957750

RE:RE:RE:RE:RE:RE:RE:For the weekend i.e. off topic -- covid related.

RE:RE:RE:RE:RE:RE:RE:For the weekend i.e. off topic -- covid related.
99942Apophis wrote: Yes Pandora it probably will do better with the 4 doses in Brazilian clinical trials.

Regardless when Theralase does go into trial with their Coronavirus treatment it will do as well or in my opinion far better than the leading vaccines available currently and any drug. Good question is will Theralase's Coronavirus treatment be able to help those that are already infected with the virus mild to severe? Anyone willing to tackle that question?


What bothers me most is that we are a good 18 months past where all this started and regardless of now being around 80% fully vaccinated we in Canada still have 50 people a day dying from Covid (if stats can be believed).

The main "therapeutic/medicine" that gets applied in the hospitals in Canada is Dexamethasone - an all purpose steroid? My wife was given this drug as an anti-nausea drug as she was fighting cancer and on chemotherapy in 2012. And it is the "prime" for covid - while over 27,000 people have died. (700K in the U.S.)

I think it is atrocious that two countries like the U.S. and Canada have not put more effort into the "therapeutic" aspect of the fight against covid while spending billions on the vaccines that may prevent people from getting the virus but do not prevent the deaths of those that do get it. And now the vaccines are showing their effectiveness is dropping off quicker than it should causing the call for "boosters". Meanwhile "breakthrough" cases are becoming a bigger factor in the "new cases" category -- up from
5% to be around 15%.

Hopefully these charts will format properly -- always a challenge on Stockhouse:(link provided just in case: https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html   )

As of October 1st, 2021:

Location New cases New deaths Tests performed
Canada 4,410 50 123,385
British Columbia 714 11 17,028
Alberta 1,630 14 17,590
Saskatchewan 471 5 3,861
Manitoba 78 0 3,568
Ontario 668 11 38,788
Quebec 643 6 34,533

 

  • Source: Detailed case information received by PHAC from provinces and territories, since December 14, 2020
Table 2. Characteristics and severe outcomes associated unvaccinated, partially vaccinated and fully vaccinated confirmed cases reported to PHAC, as of September 11, 2021
- Unvaccinated(n=642,016) Cases not yet protected(n=37,321) Partially vaccinated(n=41,562) Fully vaccinated(n=24,717) Total cases(n=745,616)
Gender* Male 327,688 (87.4%) 17,839 (4.8%) 19,207 (5.1%) 10,407 (2.8%) 375,141 (100%)
Female 311,433 (84.8%) 19,363 (5.3%) 22,218 (6.0%) 14,227 (3.9%) 367,241 (100%)
Hospitalizations 33,303 (83.8%) 2,668 (6.7%) 2,712 (6.8%) 1,059 (2.7%) 39,742 (100%)
Deaths 6,700 (80.2%) 699 (8.4%) 639 (7.7%) 312 (3.7%) 8,350 (100%)


One stat they do not appear to post any information on is how many people have natural immunity from already having had covid. It appears to be a stat they do not wish to discuss as long as the push is being made to vaccinate 100% of the population.
<< Previous
Bullboard Posts
Next >>